Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Penicillins	O
Attending:	O
___.	O
Chief	O
Complaint:	O
somnolence	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
___	O
VP	O
shunt	O
sampling	O
___	O
Tunneled	O
line	O
removal	O
___	O
Left	O
tunneled	O
line	O
placement	O
History	O
of	O
Present	O
Illness:	O
Patient	O
is	O
an	O
___	O
woman	O
w	O
hx	O
of	O
NPH	O
s/p	O
VP	O
shunt,	O
CVA	O
w	O
residual	O
R-hemiparesis	O
and	O
wheelchair-bound,	B-Bed_Chairbound
ESRD	O
on	O
HD	O
TTSa,	O
who	O
has	O
been	O
having	O
fevers	O
and	O
leukocytosis	O
x5d	O
at	O
her	O
rehab,	O
sent	O
to	O
OSH	O
for	O
somnolence	O
during	O
HD	O
on	O
___,	O
and	O
transferred	O
to	O
___	O
given	O
c/f	O
VP	O
shunt	O
malfunction	O
(ruled	O
out),	O
now	O
being	O
admitted	O
to	O
medicine	O
for	O
further	O
___	O
and	O
likely	O
infection.	O
Reportedly	O
has	O
been	O
running	O
low-grade	O
temperature	O
since	O
___	O
and	O
___,	O
was	O
started	O
on	O
7d	O
doxy	O
course	O
by	O
rehab	O
MD	O
___	O
what	O
source,	O
if	O
any,	O
was	O
being	O
targeted).	O
Per	O
daughter's	O
report,	O
patient	O
either	O
fell	B-Falls
or	O
slid	O
(daughter	O
concerned	O
rehab	O
employees	O
have	O
given	O
her	O
different	O
versions	O
of	O
events)	O
out	O
of	O
her	O
wheelchair.	B-Mobile_with_aid
Patient	O
does	O
not	O
recall	O
this.	O
Towards	O
the	O
end	O
of	O
HD	O
session	O
on	O
___,	O
noted	O
to	O
be	O
severely	O
agitated	O
(stating	O
she	O
no	O
longer	O
wants	O
HD	O
and	O
would	O
rather	O
die),	O
and	O
the	O
session	O
was	O
terminated	O
early.	O
In	O
the	O
ambulance	O
on	O
the	O
way	O
back	O
to	O
rehab,	O
she	O
was	O
noted	O
to	O
have	O
an	O
episode	O
of	O
apneic/agonal	O
breathing	O
and	O
sent	O
to	O
___	O
instead	O
for	O
further	O
evaluation.	O
At	O
___,	O
noted	O
with	O
temp	O
100.1	O
and	O
altered	B-Delirium
mental	B-Delirium
status,	B-Delirium
treated	O
for	O
presumed	O
sepsis	O
with	O
IVF,	O
vanco/aztreonam.	O
CXR	O
reportedly	O
clear.	O
Her	O
head	O
CT	O
shows	O
hydrocephalus.	O
CT	O
torso	O
was	O
unremarkable.	O
Chest	O
x-ray	O
with	O
no	O
pneumonia.	B-Lower_respiratory_tract_infection
Given	O
concern	O
for	O
possible	O
VP	O
shunt	O
malfunction/infection,	O
transferred	O
to	O
___	O
for	O
___	O
evaluation.	O
Since	O
arriving	O
at	O
___	O
___,	O
had	O
LP	O
(wnl)	O
as	O
well	O
as	O
shunt	O
study	O
per	O
___	O
recs,	O
which	O
was	O
also	O
normal.	O
Initially,	O
her	O
mental	O
status	O
improved	O
and	O
daughter	O
reported	O
patient	O
close	O
to	O
her	O
baseline,	O
awake	O
and	O
alert	O
oriented	B-Delirium
Ã—4.	B-Delirium
She	O
has	O
again	O
become	O
more	O
confused	O
throughout	O
the	O
day,	O
and	O
more	O
somnolent	O
by	O
the	O
time	O
of	O
transfer	O
to	O
the	O
floor.	O
See	O
below	O
for	O
discussion	O
w	O
daughter.	O
Of	O
note,	O
regarding	O
her	O
dialysis,	O
she	O
is	O
on	O
year	O
___	O
and	O
has	O
non-functional	O
LUE	O
AVF,	O
and	O
another	O
RUE	O
AVF	O
recently	O
revised	O
and	O
also	O
non-functional.	O
Currently	O
undergoing	O
HD	O
via	O
tunneled	O
RIJ	O
HD	O
catheter.	O
Receives	O
outpatient	O
HD	O
at	O
___	O
in	O
___.	O
Regarding	O
her	O
VP	O
shunt,	O
placed	O
in	O
___	O
to	O
treat	O
suspected	O
NPH	O
to	O
facilitate	O
improvement	O
in	O
cognition	O
and	O
ambulatory	O
status;	O
per	O
daughter	O
there	O
was	O
some	O
improvement	O
in	O
cognition	O
following	O
the	O
procedure.	O
In	O
the	O
___,	O
initial	O
vitals:	O
T	O
96.4	O
HR	O
68	O
BP	O
146/89	O
RR	O
26	O
100%	O
2L	O
NC	O
-	O
Exam	O
notable	O
for:	O
Able	O
to	O
wiggle	O
both	O
toes,	O
withdraws	O
the	O
right	O
upper	O
extremity	O
to	O
pain,	O
does	O
not	O
withdraw	O
the	O
left	O
upper	O
extremity.	O
Pupils	O
are	O
equal,	O
the	O
right	O
is	O
nonreactive,	O
the	O
left	O
is	O
reactive.	O
-	O
Labs	O
notable	O
for:	O
UA	O
>600	O
protein,	O
tr	O
glu,	O
6	O
RBCs	O
WBC	O
16.6,	O
Hgb	O
10.2,	O
MCV	O
102,	O
PLT	O
147	O
Serum	O
tox	O
negative	O
AST/ALT	O
wnl,	O
AP	O
181,	O
TBili	O
0.2	O
Trop	O
0.54	O
-->	O
0.47,	O
CK/MB	O
wnl	O
CHEM10	O
wnl	O
except	O
BUN	O
33,	O
Cr	O
3.9	O
Lactate	O
1.2	O
LP	O
-	O
Protein	O
79	O
-	O
Glucose	O
69	O
-	O
WBC	O
2,	O
RBC	O
1,	O
Poly	O
3,	O
Lymph	O
35,	O
Mono	O
44	O
-	O
Consults:	O
NSURG	O
Briefly,	O
this	O
is	O
an	O
___	O
year-old	O
female	O
with	O
multiple	O
medical	O
comorbidities	O
including	O
ESRD	O
on	O
dialysis,	O
NPH	O
s/p	O
VPS	O
placement	O
at	O
___	O
(___),	O
presenting	O
with	O
AMS.	B-Delirium
Patient	O
became	O
increasingly	O
somnolent	O
after	O
dialysis	O
this	O
afternoon.	O
Initially	O
seen	O
@	O
OSH,	O
sent	O
to	O
___	O
to	O
assess	O
shunt.	O
We	O
do	O
not	O
have	O
any	O
baseline	O
scans	O
or	O
information	O
about	O
type	O
of	O
shunt.	O
On	O
my	O
exam,	O
sleeping	O
but	O
arouses	O
to	O
stimulus,	O
interactive	O
without	O
focal	O
deficit.	O
Head	O
CT	O
with	O
ventriculomegaly	O
consistent	O
with	O
NPH,	O
right	O
frontal	O
VPS	O
in	O
appropriate	O
position.	O
Low	O
suspicion	O
for	O
acute	O
shunt	O
malfunction.	O
-	O
Imaging	O
notable	O
for:	O
XR	O
SHUNT	O
SERIES:	O
VP	O
shunt	O
appears	O
intact.	O
Mild	O
pulmonary	O
edema.	O
No	O
acute	O
abdominopelvic	O
process.	O
-	O
Pt	O
given:	O
ceftriaxone	O
2g	O
-	O
Vitals	O
prior	O
to	O
transfer:	O
HR	O
71	O
BP	O
150/47	O
RR	O
16	O
97%	O
RA	O
Upon	O
arrival	O
to	O
the	O
floor,	O
the	O
patient	O
reports	O
pain	O
in	O
RUE	O
and	O
at	O
site	O
of	O
port.	O
Unable	O
to	O
engage	O
in	O
further	O
discussion	O
due	O
to	O
AMS.	B-Delirium
Daughter	O
requested	O
to	O
speak	O
to	O
team	O
outside	O
of	O
the	O
room	O
regarding	O
her	O
mother.	O
Was	O
initially	O
very	O
worried	O
that	O
her	O
mother	O
might	O
be	O
dying	O
imminently.	O
Explained	O
our	O
concerns	O
(infection	O
vs	O
DVT),	O
and	O
she	O
understood.	O
Daughter	O
shared	O
that	O
she	O
has	O
had	O
ongoing	O
discussions	O
with	O
nephrologists	O
at	O
her	O
rehab	O
regarding	O
GOC	O
for	O
her	O
mother.	O
After	O
hearing	O
that	O
her	O
mother	O
was	O
very	O
agitated	O
at	O
HD	O
on	O
___,	O
dtr	O
more	O
concerned	O
about	O
ongoing	O
medical	O
treatment.	O
Past	O
Medical	O
History:	O
NPH	O
s/p	O
VP	O
shunt	O
CVA	O
w	O
residual	O
R-hemiparesis	O
and	O
wheelchair-bound	B-Bed_Chairbound
ESRD	O
on	O
HD	O
TTSa	O
Narcolepsy	O
without	O
cataplexy	O
Social	O
History:	O
___	O
Family	O
History:	O
non-contributory	O
Physical	O
Exam:	O
ADMISSION	O
PHSYSICAL	O
EXAM:	O
=======================	O
VITALS:	O
T	O
98.6	O
BP	O
145/57	O
HR	O
72	O
RR	O
20	O
94%Ra	O
___:	O
Opens	O
eyes	O
to	O
voice,	O
NAD	O
HEENT:	O
Anicteric,	O
dry	O
MMs	O
CHEST:	O
tunneled	O
HD	O
cath	O
w	O
clean	O
dressing,	O
extremely	O
TTP	O
CARDIAC:	O
S1	O
S2	O
RRR	O
with	O
systolic	O
murmur	O
at	O
base	O
PULM:	O
bibasilar	O
crackles	O
R>L,	O
nl	O
WOB	O
on	O
RA	O
ABD:	O
Soft,	O
NT,	O
ND,	O
no	O
guarding	O
GU:	O
No	O
foley.	O
EXT:	O
1+	O
BLE	O
edema,	O
1+RUE	O
edema,	O
RUE	O
extremely	O
TTP	O
with	O
patchy	O
erythema	O
and	O
scattered	O
bruising	O
SKIN:	O
Warm,	O
blanching	O
erythematous	O
rash	O
over	O
bilateral	O
lower	O
extremities,	O
mildly	O
tender	O
to	O
touch	O
NEURO:	O
AOx1-2	B-Unspecified_cognitive_impairment
(self,	O
"hospital	O
near	O
the	O
___"),	O
unable	O
to	O
participate	O
further	O
ACCESS:	O
Tunneled	O
right	O
IJ	O
HD	O
catheter	O
in	O
right	O
chest.	O
RUE	O
AVF	O
with	O
+	O
bruit.	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
=======================	O
24	O
HR	O
Data	O
(last	O
updated	O
___	O
@	O
724)	O
Temp:	O
98.9	O
(Tm	O
99.3),	O
BP:	O
123/67	O
(99-158/63-68),	O
HR:	O
79	O
(73-79),	O
RR:	O
18	O
(___),	O
O2	O
sat:	O
98%	O
(96-98),	O
O2	O
delivery:	O
Ra	O
___:	O
Elderly	O
female	O
in	O
NAD.	O
Lying	O
comfortably	O
in	O
bed	O
HEENT:	O
NC/AT.	O
PERRL.	O
EOMI.	O
Moist	O
mucous	O
membranes.	O
NECK:	O
Supple,	O
no	O
lymphadenopathy	O
CHEST:	O
Left	O
sided	O
HD	O
line,	O
some	O
dried	O
blood	O
around	O
the	O
site,	O
otherwise	O
non-tender	O
CARDIAC:	O
RRR	O
with	O
normal	O
S1	O
and	O
S2.	O
II/VI	O
SEM	O
at	O
RUSB,	O
LUSB,	O
and	O
apex.	O
No	O
rubs	O
or	O
gallops.	O
PULM:	O
Anterior	O
lung	O
fields	O
clear.	O
ABD:	O
Soft,	O
NT/ND,	O
normoactive	O
BS.	O
No	O
guarding	O
or	O
masses.	O
EXT:	O
Warm,	O
well	O
perfused.	O
Compression	O
stockings	O
in	O
place,	O
no	O
___	O
edema.	O
NEURO:	O
AOx2-3,	B-Delirium
CN	O
II-XII	O
intact.	O
Moving	O
all	O
extremities	O
with	O
purpose	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
==============	O
___	O
09:50PM	O
BLOOD	O
WBC-16.6*	O
RBC-3.38*	O
Hgb-10.2*	O
Hct-34.4	O
MCV-102*	O
MCH-30.2	O
MCHC-29.7*	O
RDW-15.9*	O
RDWSD-59.8*	O
Plt	O
___	O
___	O
09:50PM	O
BLOOD	O
Neuts-80.7*	O
Lymphs-9.2*	O
Monos-7.6	O
Eos-0.5*	O
Baso-0.2	O
Im	O
___	O
AbsNeut-13.41*	O
AbsLymp-1.53	O
AbsMono-1.27*	O
AbsEos-0.09	O
AbsBaso-0.04	O
___	O
09:50PM	O
BLOOD	O
Glucose-100	O
UreaN-33*	O
Creat-3.9*	O
Na-140	O
K-3.6	O
Cl-97	O
HCO3-26	O
AnGap-17	O
___	O
09:50PM	O
BLOOD	O
ALT-17	O
AST-25	O
CK(CPK)-69	O
AlkPhos-181*	O
TotBili-0.2	O
___	O
09:50PM	O
BLOOD	O
CK-MB-2	O
cTropnT-0.54*	O
___	O
09:50PM	O
BLOOD	O
Albumin-3.4*	O
Calcium-9.1	O
Phos-3.3	O
Mg-1.9	O
___	O
09:58PM	O
BLOOD	O
Lactate-1.2	O
PERTINENT	O
LABS/MICRO:	O
====================	O
___	O
09:50PM	O
BLOOD	O
WBC-16.6*	O
RBC-3.38*	O
Hgb-10.2*	O
Hct-34.4	O
MCV-102*	O
MCH-30.2	O
MCHC-29.7*	O
RDW-15.9*	O
RDWSD-59.8*	O
Plt	O
___	O
___	O
09:50PM	O
BLOOD	O
CK-MB-2	O
cTropnT-0.54*	O
___	O
03:37AM	O
BLOOD	O
cTropnT-0.47*	O
___	O
06:00PM	O
BLOOD	O
cTropnT-0.45*	O
___	O
11:29AM	O
BLOOD	O
CK-MB-2	O
cTropnT-0.49*	O
___	O
08:35PM	O
BLOOD	O
CK-MB-2	O
cTropnT-0.36*	O
___	O
09:50PM	O
BLOOD	O
ASA-NEG	O
Ethanol-NEG	O
Acetmnp-NEG	O
Bnzodzp-NEG	O
Barbitr-NEG	O
Tricycl-NEG	O
___	O
09:58PM	O
BLOOD	O
Lactate-1.2	O
___	O
06:28PM	O
BLOOD	O
Lactate-1.4	O
___	O
08:46PM	O
URINE	O
Color-Yellow	O
Appear-Hazy*	O
Sp	O
___	O
___	O
08:46PM	O
URINE	O
Blood-NEG	O
Nitrite-NEG	O
Protein->600*	O
Glucose-TR*	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-8.0	O
Leuks-NEG	O
___	O
08:46PM	O
URINE	O
RBC-6*	O
WBC-3	O
Bacteri-NONE	O
Yeast-NONE	O
Epi-<1	O
___	O
03:12AM	O
CEREBROSPINAL	O
FLUID	O
(CSF)	O
TNC-2	O
RBC-1	O
Polys-3	O
___	O
___	O
03:12AM	O
CEREBROSPINAL	O
FLUID	O
(CSF)	O
TotProt-79*	O
Glucose-69	O
___	O
Urine	O
culture:	O
No	O
growth	O
___	O
CSF	O
culture:	O
No	O
growth	O
___	O
BCx	O
x2:	O
NGTD	O
___	O
2:50	O
pm	O
BLOOD	O
CULTURE	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
STAPHYLOCOCCUS	O
EPIDERMIDIS.	O
Susceptibility	O
testing	O
requested	O
per	O
___.	O
___	O
(___)	O
ON	O
___.	O
FINAL	O
SENSITIVITIES.	O
COAG	O
NEG	O
STAPH	O
does	O
NOT	O
require	O
contact	O
precautions,	O
regardless	O
of	O
resistance.	O
Oxacillin	O
RESISTANT	O
Staphylococci	O
MUST	O
be	O
reported	O
as	O
also	O
RESISTANT	O
to	O
other	O
penicillins,	O
cephalosporins,	O
carbacephems,	O
carbapenems,	O
and	O
beta-lactamase	O
inhibitor	O
combinations.	O
RIFAMPIN	O
should	O
not	O
be	O
used	O
alone	O
for	O
therapy.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
STAPHYLOCOCCUS	O
EPIDERMIDIS	O
|	O
CLINDAMYCIN-----------	O
=>8	O
R	O
ERYTHROMYCIN----------	O
=>8	O
R	O
GENTAMICIN------------	O
8	O
I	O
LEVOFLOXACIN----------	O
=>8	O
R	O
OXACILLIN-------------	O
=>4	O
R	O
RIFAMPIN--------------	O
<=0.5	O
S	O
VANCOMYCIN------------	O
2	O
S	O
Time	O
Taken	O
Not	O
Noted	O
Log-In	O
Date/Time:	O
___	O
7:22	O
am	O
BLOOD	O
CULTURE	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
STAPHYLOCOCCUS	O
EPIDERMIDIS.	O
FINAL	O
SENSITIVITIES.	O
Oxacillin	O
RESISTANT	O
Staphylococci	O
MUST	O
be	O
reported	O
as	O
also	O
RESISTANT	O
to	O
other	O
penicillins,	O
cephalosporins,	O
carbacephems,	O
carbapenems,	O
and	O
beta-lactamase	O
inhibitor	O
combinations.	O
RIFAMPIN	O
should	O
not	O
be	O
used	O
alone	O
for	O
therapy.	O
COAG	O
NEG	O
STAPH	O
does	O
NOT	O
require	O
contact	O
precautions,	O
regardless	O
of	O
resistance.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
STAPHYLOCOCCUS	O
EPIDERMIDIS	O
|	O
CLINDAMYCIN-----------	O
=>8	O
R	O
ERYTHROMYCIN----------	O
=>8	O
R	O
GENTAMICIN------------	O
8	O
I	O
LEVOFLOXACIN----------	O
=>8	O
R	O
OXACILLIN-------------	O
=>4	O
R	O
RIFAMPIN--------------	O
<=0.5	O
S	O
VANCOMYCIN------------	O
1	O
S	O
___	O
7:40	O
am	O
BLOOD	O
CULTURE	O
**FINAL	O
REPORT	O
___	O
Blood	O
Culture,	O
Routine	O
(Final	O
___:	O
STAPHYLOCOCCUS	O
EPIDERMIDIS.	O
FINAL	O
SENSITIVITIES.	O
Oxacillin	O
RESISTANT	O
Staphylococci	O
MUST	O
be	O
reported	O
as	O
also	O
RESISTANT	O
to	O
other	O
penicillins,	O
cephalosporins,	O
carbacephems,	O
carbapenems,	O
and	O
beta-lactamase	O
inhibitor	O
combinations.	O
RIFAMPIN	O
should	O
not	O
be	O
used	O
alone	O
for	O
therapy.	O
COAG	O
NEG	O
STAPH	O
does	O
NOT	O
require	O
contact	O
precautions,	O
regardless	O
of	O
resistance.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
STAPHYLOCOCCUS	O
EPIDERMIDIS	O
|	O
CLINDAMYCIN-----------	O
=>8	O
R	O
ERYTHROMYCIN----------	O
=>8	O
R	O
GENTAMICIN------------	O
8	O
I	O
LEVOFLOXACIN----------	O
=>8	O
R	O
OXACILLIN-------------	O
=>4	O
R	O
RIFAMPIN--------------	O
<=0.5	O
S	O
VANCOMYCIN------------	O
1	O
S	O
___	O
7:00	O
am	O
BLOOD	O
CULTURE	O
#1.	O
Blood	O
Culture,	O
Routine	O
(Preliminary):	O
STAPHYLOCOCCUS,	O
COAGULASE	O
NEGATIVE.	O
SENSITIVITIES	O
PERFORMED	O
ON	O
REQUEST..	O
Aerobic	O
Bottle	O
Gram	O
Stain	O
(Final	O
___:	O
GRAM	O
POSITIVE	O
COCCI	O
IN	O
PAIRS	O
AND	O
CLUSTERS.	O
Reported	O
to	O
and	O
read	O
back	O
by	O
___	O
___	O
07:23	O
X	O
___.	O
___	O
5:42	O
pm	O
CATHETER	O
TIP-IV	O
Source:	O
HD	O
line.	O
**FINAL	O
REPORT	O
___	O
WOUND	O
CULTURE	O
(Final	O
___:	O
No	O
significant	O
growth.	O
Blood	O
culture	O
___	O
and	O
___	O
no	O
growth	O
to	O
date	O
DISCHARGE	O
LABS:	O
===============	O
___	O
06:45AM	O
BLOOD	O
WBC-8.8	O
RBC-3.23*	O
Hgb-10.3*	O
Hct-33.2*	O
MCV-103*	O
MCH-31.9	O
MCHC-31.0*	O
RDW-16.4*	O
RDWSD-61.9*	O
Plt	O
___	O
___	O
06:45AM	O
BLOOD	O
Glucose-103*	O
UreaN-22*	O
Creat-4.2*#	O
Na-138	O
K-4.9	O
Cl-95*	O
HCO3-27	O
AnGap-16	O
PERTINENT	O
IMAGING:	O
================	O
___	O
Shunt	O
Series:	O
VP	O
shunt	O
appears	O
intact.	O
Mild	O
pulmonary	O
edema.	O
No	O
acute	O
abdominopelvic	O
process.	O
___	O
RUE	O
ultrasound:	O
No	O
evidence	O
of	O
deep	O
vein	O
thrombosis	O
in	O
the	O
right	O
upper	O
extremity.	O
___	O
TTE	O
The	O
left	O
atrial	O
volume	O
index	O
is	O
normal.	O
There	O
is	O
normal	O
left	O
ventricular	O
wall	O
thickness	O
with	O
a	O
normal	O
cavity	O
size.	O
There	O
is	O
mild	O
regional	O
left	O
ventricular	O
systolic	O
dysfunction	O
with	O
akinesis	O
of	O
the	O
inferobasal	O
wall	O
and	O
hypokinesis	O
of	O
the	O
mid	O
inferior	O
wall,	O
basal	O
to	O
mid	O
inferolateral	O
wall,	O
and	O
basal	O
to	O
mid	O
inferoseptum	O
(see	O
schematic)	O
and	O
preserved/normal	O
contractility	O
of	O
the	O
remaining	O
segments.	O
Left	O
ventricular	O
cardiac	O
index	O
is	O
high	O
(>4.0	O
L/min/	O
m2).	O
There	O
is	O
no	O
resting	O
left	O
ventricular	O
outflow	O
tract	O
gradient.	O
Tissue	O
Doppler	O
suggests	O
an	O
increased	O
left	O
ventricular	O
filling	O
pressure	O
(PCWP	O
greater	O
than	O
18mmHg).	O
Normal	O
right	O
ventricular	O
cavity	O
size	O
with	O
normal	O
free	O
wall	O
motion.	O
The	O
aortic	O
sinus	O
diameter	O
is	O
normal	O
for	O
gender	O
with	O
normal	O
ascending	O
aorta	O
diameter	O
for	O
gender.	O
The	O
aortic	O
arch	O
diameter	O
is	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
aortic	O
valve	O
stenosis.	O
There	O
is	O
no	O
aortic	O
regurgitation.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
with	O
no	O
mitral	O
valve	O
prolapse.	O
There	O
is	O
moderate	O
mitral	O
annular	O
calcification.	O
There	O
is	O
an	O
eccentric,	O
inferolateral	O
directed	O
jet	O
of	O
moderate	O
[2+]	O
mitral	O
regurgitation.	O
Due	O
to	O
acoustic	O
shadowing,	O
the	O
severity	O
of	O
mitral	O
regurgitation	O
could	O
be	O
UNDERestimated.	O
The	O
tricuspid	O
valve	O
leaflets	O
appear	O
structurally	O
normal.	O
There	O
is	O
no	O
tricuspid	O
regurgitation.	O
The	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
is	O
normal.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
IMPRESSION:	O
Mild	O
regional	O
left	O
ventricular	O
systolic	O
dysfunction	O
most	O
consistent	O
with	O
single	O
vessel	O
coronary	O
artery	O
disease	O
(PDA	O
distribution).	O
Moderate,	O
eccentric	O
posteriorly	O
directed	O
mitral	O
regurgitation.	O
Brief	O
Hospital	O
Course:	O
Ms.	O
___	O
is	O
an	O
___	O
year	O
old	O
woman	O
with	O
a	O
hx	O
of	O
NPH	O
s/p	O
VP	O
shunt,	O
CVA	O
w	O
residual	O
R-hemiparesis,	O
and	O
ESRD	O
on	O
HD	O
___	O
who	O
presented	O
from	O
OSH	O
for	O
VP	O
shunt	O
evaluation	O
in	O
the	O
setting	O
of	O
encephalopathy.	O
She	O
was	O
cleared	O
by	O
neurosurgery,	O
and	O
then	O
admitted	O
to	O
medication	O
for	O
leukocytosis	O
and	O
fevers.	O
Her	O
course	O
was	O
notable	O
for	O
cellulitis	O
of	O
the	O
right	O
upper	O
extremity	O
overlying	O
site	O
of	O
(nonfunctioning)	O
AVF	O
and	O
staph	O
epidermidis	O
bacteremia.	O
She	O
underwent	O
removal	O
of	O
her	O
right	O
tunneled	O
HD	O
line	O
on	O
___	O
and	O
placement	O
of	O
new	O
left	O
tunneled	O
HD	O
line	O
on	O
___.	O
ACUTE	O
ISSUES:	O
=============	O
#	O
Leukocytosis,	O
fevers	O
#	O
Cellulitis	O
of	O
RUE	O
fistula	O
#	O
Staph	O
epi	O
bacteremia	O
Skin	O
exam	O
was	O
concerning	O
for	O
cellulitis	O
given	O
RUE	O
erythema	O
and	O
swelling	O
surrounding	O
the	O
right	O
fistula,	O
which	O
improved	O
after	O
initiation	O
of	O
vancomycin.	O
On	O
___	O
she	O
was	O
found	O
to	O
have	O
staph	O
epi	O
bacteremia,	O
with	O
blood	O
cultures	O
continuing	O
to	O
return	O
positive	O
through	O
___.	O
Infectious	O
disease	O
was	O
consulted.	O
Concern	O
for	O
line	O
infection	O
so	O
vanc	O
locks	O
were	O
started	O
for	O
HD	O
line.	O
Given	O
persistent	O
bacteremia	O
HD	O
line	O
was	O
removed	O
and	O
patient	O
had	O
line	O
holiday	O
for	O
72	O
hours	O
with	O
negative	O
cultures	O
before	O
line	O
was	O
replaced	O
(pulled	O
___,	O
replaced	O
___.	O
TTE	O
was	O
negative	O
for	O
vegetations	O
and	O
upon	O
discussion	O
with	O
ID,	O
this	O
organism	O
is	O
low	O
risk	O
for	O
endocarditis	O
and	O
the	O
risk	O
of	O
pursuing	O
TEE	O
outweighed	O
the	O
benefits.	O
She	O
will	O
be	O
discharged	O
to	O
complete	O
a	O
2	O
week	O
course	O
of	O
vancomycin,	O
dosed	O
at	O
HD,	O
with	O
day	O
1	O
being	O
the	O
day	O
of	O
line	O
removal.	O
Abx	O
course	O
___.	O
#	O
NPH	O
s/p	O
VP	O
shunt	O
#	O
Toxic	O
metabolic	O
encephalopathy	B-Delirium
Presented	O
with	O
several	O
days	O
of	O
fevers	O
and	O
altered	B-Delirium
mental	B-Delirium
status,	B-Delirium
found	O
to	O
have	O
leukocytosis	O
concerning	O
for	O
infection.	O
CT	O
head	O
at	O
OSH	O
showed	O
hydrocephalus	O
and	O
CT	O
chest/abd/pelvis	O
was	O
unremarkable.	O
She	O
was	O
transferred	O
to	O
___	O
for	O
shunt	O
evaluation,	O
which	O
was	O
felt	O
to	O
be	O
functioning	O
after	O
a	O
shunt	O
series	O
and	O
neurosurgery	O
evaluation.	O
Etiology	O
of	O
her	O
altered	B-Delirium
mental	B-Delirium
status	B-Delirium
was	O
felt	O
to	O
be	O
due	O
to	O
toxic	O
metabolic	O
encephalopathy	B-Delirium
in	O
the	O
setting	O
of	O
infection	O
described	O
above.	O
#	O
Type	O
II	O
NSTEMI	O
#	O
Bradycardia	O
Troponin	O
0.54	O
on	O
admission	O
and	O
quickly	O
downtrended	O
to	O
0.45.	O
The	O
patient	O
also	O
had	O
an	O
episode	O
of	O
reported	O
bradycardia	O
to	O
the	O
___	O
monitor	O
reported	O
___,	O
while	O
EKG	O
recorded	O
HR	O
of	O
___,	O
so	O
unclear	O
if	O
true	O
bradycardia.	O
Likely	O
bigeminy	O
PVCs	O
as	O
EKG	O
was	O
consistent	O
with	O
rate	O
in	O
the	O
60-70s.	O
Her	O
home	O
carvedilol	O
was	O
held.	O
Troponin	O
was	O
rechecked	O
and	O
remained	O
in	O
the	O
0.3-0.5	O
range.	O
EKG	O
remained	O
unchanged	O
and	O
the	O
patient	O
was	O
never	O
symptomatic.	O
TTE	O
showed	O
"Mild	O
regional	O
left	O
ventricular	O
systolic	O
dysfunction	O
most	O
consistent	O
with	O
single	O
vessel	O
coronary	O
artery	O
disease	O
(PDA	O
distribution)."	O
Recommend	O
further	O
evaluation	O
as	O
an	O
outpatient	O
and	O
medical	O
optimization:	O
she	O
is	O
already	O
on	O
an	O
aspirin	O
and	O
statin;	O
holding	O
carvedilol	O
as	O
above.	O
#	O
RUE	O
swelling/pain	O
Presented	O
with	O
RUE	O
swelling	O
and	O
pain	O
concerning	O
for	O
infection	O
vs	O
DVT.	O
RUE	O
ultrasound	O
was	O
negative	O
for	O
clot.	O
Infection	O
treated	O
as	O
above.	O
#	O
Sacral	O
tissue	O
erosion,	O
reported	O
a	O
history	O
of	O
sacral	O
wound.	B-Pressure_injury
Evaluated	O
by	O
wound	B-Pressure_injury
care	O
and	O
not	O
consistent	O
with	O
pressure	B-Pressure_injury
injury	B-Pressure_injury
but	O
scattered	O
areas	O
of	O
tissue	O
erosion,	O
secondary	O
to	O
fecal	I-Faecal_incontinence
incontinence.	B-Faecal_incontinence
#Goals	O
of	O
care	O
#Depression	O
#Bipolar	O
disorder	O
She	O
was	O
continued	O
on	O
her	O
home	O
escitalopram.	O
Mirtazapine	O
was	O
held	O
initially	O
due	O
to	O
encephalopathy	B-Delirium
but	O
resumed	O
prior	O
to	O
discharge.	O
She	O
intermittently	O
was	O
refusing	O
care	O
(bowel	O
medications,	O
fistulogram,	O
SC	O
heparin,	O
etc).	O
On	O
admission,	O
the	O
patient's	O
daughter	O
expressed	O
concerns	O
that	O
HD	O
was	O
making	O
her	O
mother	O
miserable	O
and	O
noted	O
that	O
her	O
mother	O
had	O
been	O
frequent	O
in	O
hospitals	O
/rehabs	O
over	O
the	O
last	O
several	O
months.	O
Several	O
goals	O
of	O
care	O
discussions	O
occurred	O
and	O
palliative	O
care	O
was	O
consulted.	O
Patient	O
shared	O
that	O
her	O
goal	O
is	O
ultimately	O
to	O
get	O
home.	O
She	O
shared	O
that	O
for	O
now	O
she	O
wants	O
to	O
continue	O
all	O
treatments,	O
including	O
procedures	O
and	O
IVs,	O
if	O
this	O
means	O
she	O
can	O
one	O
day	O
get	O
home.	O
She	O
was	O
still	O
had	O
a	O
very	O
depressed	O
mood	O
and	O
despite	O
these	O
conversations	O
often	O
refused	O
care.	O
Code	O
status	O
discussion	O
was	O
felt	O
not	O
be	O
productive	O
or	O
reliable	O
in	O
the	O
setting	O
of	O
severe	O
depression/passive	O
suicidal	O
ideation	O
while	O
inpatient.	O
Continued	O
home	O
mirtazepine	O
and	O
escitalopram.	O
#	O
QTc	O
prolonged	O
500/515	O
on	O
admission	O
EKG.	O
Rechecks	O
___	O
and	O
___	O
were	O
normal(470)	O
but	O
___	O
with	O
QTc	O
538.	O
QTC	O
prior	O
to	O
discharge	O
on	O
___	O
was	O
499.	O
Avoid	O
additional	O
QT	O
prolonging	O
medications.	O
CHRONIC	O
ISSUES:	O
================	O
#	O
ESRD	O
on	O
HD	O
The	O
patient	O
continued	O
on	O
HD	O
on	O
___	O
(held	O
during	O
line	O
holiday)	O
and	O
her	O
home	O
medications	O
without	O
issues.	O
#	O
Prior	O
CVA,	O
residual	O
deficits	O
uncertain	O
#	O
Wheelchair-dependent	B-Mobile_with_aid
at	O
___	O
rehab	O
Pt	O
deconditioned	O
and	O
wheelchair	B-Bed_Chairbound
bound	B-Bed_Chairbound
at	O
baseline.	O
She	O
worked	O
with	O
physical	O
therapy	O
while	O
inpatient.	O
#	O
T2DM	O
Home	O
Januvia	O
was	O
held	O
on	O
admission	O
and	O
the	O
patient's	O
BG	O
was	O
controlled	O
with	O
sliding	O
scale	O
insulin.	O
#	O
HTN	O
Presented	O
on	O
amlodipine,	O
carvedilol	O
and	O
hydralazine	O
as	O
outpatient.	O
All	O
blood	O
pressure	O
medications	O
were	O
initially	O
held	O
given	O
concern	O
for	O
infection	O
and	O
then	O
an	O
episode	O
of	O
bradycardia.	O
Amlodipine	O
and	O
hydralazine	O
resumed	O
prior	O
to	O
discharge.	O
Carvedilol	O
held	O
as	O
above.	O
#	O
Anemia	O
Hgb	O
at	O
around	O
her	O
baseline	O
on	O
admission.	O
Likely	O
due	O
to	O
chronic	O
kidney	O
disease.	O
TRANSITIONAL	O
ISSUES	O
===========================	O
[]	O
Code	O
status	O
should	O
be	O
addressed	O
with	O
patient	O
once	O
she	O
is	O
out	O
of	O
the	O
hospital	O
and	O
not	O
acutely	O
ill.	O
Code	O
status	O
discussion	O
was	O
felt	O
not	O
be	O
productive	O
or	O
reliable	O
in	O
the	O
setting	O
of	O
depression/passive	O
suicidal	O
ideation	O
while	O
inpatient.	O
Please	O
involve	O
pt's	O
daughter	O
in	O
these	O
discussions.	O
[]	O
Abx	O
course	O
to	O
complete	O
___.	O
Vancomycin	O
should	O
be	O
dosed	O
with	O
dialysis.	O
[]	O
Inpatient	O
transplant	O
team	O
recommending	O
fistulogram	O
for	O
further	O
evaluation	O
of	O
right	O
upper	O
extremity	O
fistula.	O
[]	O
Mild	O
regional	O
left	O
ventricular	O
systolic	O
dysfunction	O
most	O
consistent	O
with	O
single	O
vessel	O
coronary	O
artery	O
disease	O
(PDA	O
distribution)	O
seen	O
on	O
TTE.	O
Consider	O
additional	O
evaluation	O
as	O
outpatient	O
with	O
stress	O
test	O
or	O
LHC	O
if	O
within	O
patient's	O
goals	O
of	O
care.	O
[]	O
Carvedilol	O
held	O
at	O
discharge.	O
Discuss	O
restarting	O
low	O
dose	O
3.125	O
mg	O
BID	O
if	O
heart	O
rates	O
and	O
blood	O
pressure	O
will	O
allow.	O
[]	O
Limit	O
QTc	O
prolonging	O
medications.	O
[]	O
Patient	O
with	O
LEFT	O
tunneled	O
HD	O
line,	O
provide	O
care	O
as	O
appropriate	O
#	O
Contact/HCP:	O
___,	O
daughter/HCP,	O
___	O
#	O
Code	O
status:	O
Full	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
HydrALAZINE	O
10	O
mg	O
PO	O
Q8H	O
2.	O
sevelamer	O
CARBONATE	O
1600	O
mg	O
PO	O
TID	O
W/MEALS	O
3.	O
LORazepam	O
0.5	O
mg	O
PO	O
BID:PRN	O
anixety	O
4.	O
Doxycycline	O
Hyclate	O
100	O
mg	O
PO	O
Q12H	O
5.	O
Latuda	O
(lurasidone)	O
40	O
mg	O
oral	O
QPM	O
6.	O
Mirtazapine	O
15	O
mg	O
PO	O
QHS	O
7.	O
amLODIPine	O
10	O
mg	O
PO	O
DAILY	O
8.	O
Modafinil	O
100	O
mg	O
PO	O
DAILY	O
9.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
10.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
11.	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
12.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
13.	O
Carvedilol	O
6.25	O
mg	O
PO	O
DAILY	O
14.	O
Citrucel	O
(methylcellulose	O
(laxative))	O
1000	O
mg	O
oral	O
DAILY	O
15.	O
Senna	O
17.2	O
mg	O
PO	O
QHS	O
16.	O
Escitalopram	O
Oxalate	O
20	O
mg	O
PO	O
DAILY	O
17.	O
Januvia	O
(SITagliptin)	O
25	O
mg	O
oral	O
DAILY	O
18.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
19.	O
Acetaminophen	O
325-650	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild/Fever	O
20.	O
Bisacodyl	O
10	O
mg	O
PR	O
QHS:PRN	O
Constipation	B-Constipation
-	O
Third	O
Line	O
21.	O
Cyanocobalamin	O
500	O
mcg	O
PO	O
DAILY	O
22.	O
Insulin	O
SC	O
Sliding	O
Scale	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
HUM	O
Insulin	O
23.	O
Aranesp	O
(in	O
polysorbate)	O
(darbepoetin	O
alfa	O
in	O
polysorbat)	O
0	O
unknown	O
injection	O
unknown	O
24.	O
Cinacalcet	O
60	O
mg	O
PO	O
DAILY	O
25.	O
Lidocaine	O
5%	O
Ointment	O
1	O
Appl	O
TP	O
ONCE	O
Discharge	O
Medications:	O
1.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
BID	O
Hold	O
for	O
loose	O
stools.	O
2.	O
___	O
MD	O
to	O
order	O
daily	O
dose	O
IV	O
HD	O
PROTOCOL	O
this	O
will	O
be	O
ordered	O
with	O
dialysis.	O
last	O
day	O
___.	O
3.	O
Insulin	O
SC	O
Sliding	O
Scale	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
HUM	O
Insulin	O
4.	O
Acetaminophen	O
325-650	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild/Fever	O
5.	O
amLODIPine	O
10	O
mg	O
PO	O
DAILY	O
6.	O
Aranesp	O
(in	O
polysorbate)	O
(darbepoetin	O
alfa	O
in	O
polysorbat)	O
0	O
unknown	O
injection	O
Frequency	O
is	O
Unknown	O
7.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
8.	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
9.	O
Bisacodyl	O
10	O
mg	O
PR	O
QHS:PRN	O
Constipation	B-Constipation
-	O
Third	O
Line	O
10.	O
Cinacalcet	O
60	O
mg	O
PO	O
DAILY	O
11.	O
Citrucel	O
(methylcellulose	O
(laxative))	O
1000	O
mg	O
oral	O
DAILY	O
Hold	O
for	O
loose	O
stools.	O
12.	O
Cyanocobalamin	O
500	O
mcg	O
PO	O
DAILY	O
13.	O
Escitalopram	O
Oxalate	O
20	O
mg	O
PO	O
DAILY	O
14.	O
HydrALAZINE	O
10	O
mg	O
PO	O
Q8H	O
15.	O
Januvia	O
(SITagliptin)	O
25	O
mg	O
oral	O
DAILY	O
16.	O
Latuda	O
(lurasidone)	O
40	O
mg	O
oral	O
QPM	O
17.	O
Lidocaine	O
5%	O
Ointment	O
1	O
Appl	O
TP	O
ONCE	O
18.	O
LORazepam	O
0.5	O
mg	O
PO	O
BID:PRN	O
anixety	O
19.	O
Mirtazapine	O
15	O
mg	O
PO	O
QHS	O
20.	O
Modafinil	O
100	O
mg	O
PO	O
DAILY	O
21.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
22.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
23.	O
Senna	O
17.2	O
mg	O
PO	O
QHS	O
Hold	O
for	O
loose	O
stools.	O
24.	O
sevelamer	O
CARBONATE	O
1600	O
mg	O
PO	O
TID	O
W/MEALS	O
25.	O
HELD-	O
Carvedilol	O
6.25	O
mg	O
PO	O
DAILY	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Carvedilol	O
until	O
your	O
doctor	O
tells	O
you	O
to	O
restart	O
it	O
26.	O
HELD-	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Docusate	O
Sodium	O
until	O
your	O
doctor	O
restarts	O
it.	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
#Primary	O
Altered	B-Delirium
mental	B-Delirium
status	B-Delirium
Toxic	O
metabolic	O
encephalopathy	B-Delirium
Sepsis	O
from	O
a	O
bloodstream	O
infection	O
Right	O
upper	O
extremity	O
cellulitis	O
#Secondary	O
NSTEMI,	O
type	O
II	O
ESRD	O
on	O
HD	O
Normal	O
pressure	O
hydrocephalus	O
DM	O
type	O
II	O
Hypertension	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
pleasure	O
caring	O
for	O
you	O
at	O
___	O
___!	O
Why	O
you	O
were	O
admitted	O
to	O
the	O
hospital:	O
-	O
You	O
were	O
having	O
fevers	O
and	O
then	O
became	O
confused.	B-Delirium
-	O
You	O
were	O
transferred	O
from	O
___	O
to	O
ensure	O
that	O
there	O
was	O
not	O
an	O
infection	O
or	O
problem	O
of	O
your	O
shunt.	O
What	O
happened	O
while	O
you	O
were	O
here:	O
-	O
Imaging	O
showed	O
that	O
your	O
VP	O
shunt	O
was	O
working	O
well.	O
-	O
You	O
were	O
treated	O
for	O
a	O
skin	O
infection	O
of	O
your	O
right	O
arm,	O
which	O
led	O
to	O
an	O
infection	O
of	O
your	O
blood.	O
-	O
Your	O
blood	O
cultures	O
were	O
positive	O
for	O
bacteria	O
for	O
several	O
days	O
so	O
we	O
had	O
to	O
remove	O
your	O
dialysis	O
line	O
in	O
order	O
to	O
help	O
get	O
rid	O
of	O
the	O
infection.	O
Once	O
your	O
blood	O
cultures	O
stopped	O
growing	O
bacteria	O
we	O
put	O
your	O
line	O
back	O
in	O
so	O
that	O
you	O
could	O
get	O
dialysis.	O
-	O
The	O
transplant	O
surgeons	O
evaluated	O
your	O
fistula	O
and	O
recommended	O
a	O
procedure	O
called	O
a	O
fistulogram	O
but	O
you	O
declined.	O
What	O
you	O
should	O
do	O
once	O
you	O
leave	O
the	O
hospital:	O
-	O
Continue	O
taking	O
your	O
medications	O
as	O
prescribed.	O
-	O
The	O
last	O
day	O
of	O
IV	O
vancomycin	O
is	O
___.	O
You	O
will	O
get	O
this	O
medication	O
at	O
dialysis.	O
-	O
Follow	O
up	O
at	O
the	O
appointments	O
outlined	O
below.	O
Sincerely,	O
Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

